ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986

April issue of Business & Regulatory Report included (8 additional pages).

April 30, 2004

December Business & Regulatory Report included in this issue.

December 12, 2003

South Carolina Politicos Join Hollings Oncology Center Section

October 30, 1992

Funding opportunities listed.

March 12, 2004

Advisors Suggest Consortia For Lung Cancer Research.

November 9, 2001